{
  "abstract": "Objectives To explore healthcare professionals’ perspectives on the potential role of molecular breast imaging (MBI) for breast cancer imaging and to inform future clinical study design and implementation.Design Qualitative interview study.Setting UK National Health Service (NHS) breast screening and diagnostic pathways.Participants Purposively sampled stakeholders.Method Semistructured interviews with key professional stakeholders explored potential MBI pathways and routes to adoption, including barriers and facilitators. Data were analysed thematically.Results 22 participants were recruited between January 2020 and October 2021. Barriers to MBI adoption were identified at three levels: scan-related, system-level, and cultural within the screening programme. Overcoming these is likely necessary for implementation. A further theme highlighted the potential for MBI to improve screening in selected patient groups, contingent on addressing these barriers. Specifically, adoption would require advances in next-generation MBI systems, particularly reductions in radiation dose and scan time, alongside prospective clinical studies in UK populations to assess diagnostic accuracy.Conclusions Once identified barriers are overcome, participants perceived that MBI could improve screening pathways, particularly for women with dense breast tissue.",
  "authors": [
    {
      "affiliations": [
        "Northern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK",
        "Newcastle University, Newcastle upon Tyne, England, UK"
      ],
      "name": "Helen Elliott"
    },
    {
      "affiliations": [
        "Newcastle University, Newcastle upon Tyne, England, UK",
        "NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne, England, UK"
      ],
      "name": "A. Joy Allen"
    },
    {
      "affiliations": [
        "Newcastle University, Newcastle upon Tyne, England, UK",
        "Radiology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, England, UK"
      ],
      "name": "Nerys D Forester"
    },
    {
      "affiliations": [
        "NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne, England, UK",
        "Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"
      ],
      "name": "Sara Graziadio"
    },
    {
      "affiliations": [
        "Newcastle University, Newcastle upon Tyne, England, UK",
        "NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne, England, UK"
      ],
      "name": "William Stephen Jones"
    },
    {
      "affiliations": [
        "Newcastle University, Newcastle upon Tyne, England, UK",
        "NIHR Newcastle In Vitro Diagnostics Co-operative, Newcastle upon Tyne, England, UK"
      ],
      "name": "Clare Lendrem"
    },
    {
      "affiliations": [
        "Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, England, UK"
      ],
      "name": "Mark Pearce"
    },
    {
      "affiliations": [
        "Northern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK",
        "Newcastle University, Newcastle upon Tyne, England, UK"
      ],
      "name": "Timothy Powell"
    },
    {
      "affiliations": [
        "Northern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK",
        "Newcastle University, Newcastle upon Tyne, England, UK"
      ],
      "name": "Alison Bray"
    },
    {
      "affiliations": [
        "Faculty of Health and Wellbeing, Northumbria University, Newcastle upon Tyne, UK"
      ],
      "name": "Jason Scott"
    }
  ],
  "title": "Is molecular breast imaging suitable for use in UK breast cancer pathways? A qualitative study exploring healthcare professionals’ perspectives",
  "uid": "9de644fb-0ba5-5ec0-874f-92f3c4bb2caa"
}